0001140361-22-030318.txt : 20220818 0001140361-22-030318.hdr.sgml : 20220818 20220818213002 ACCESSION NUMBER: 0001140361-22-030318 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220816 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cheav Sotheara CENTRAL INDEX KEY: 0001721279 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38273 FILM NUMBER: 221178822 MAIL ADDRESS: STREET 1: C/O ACM RESEARCH, INC. STREET 2: 42307 OSGOOD ROAD, SUITE I CITY: FREMONT STATE: CA ZIP: 94539 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACM Research, Inc. CENTRAL INDEX KEY: 0001680062 STANDARD INDUSTRIAL CLASSIFICATION: SPECIAL INDUSTRY MACHINERY, NEC [3559] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 42307 OSGOOD ROAD, SUITE I CITY: FREMONT STATE: CA ZIP: 94539 BUSINESS PHONE: 510-445-3700 MAIL ADDRESS: STREET 1: 42307 OSGOOD ROAD, SUITE I CITY: FREMONT STATE: CA ZIP: 94539 4 1 form4.xml FORM 4 X0306 4 2022-08-16 0001680062 ACM Research, Inc. ACMR 0001721279 Cheav Sotheara C/O ACM RESEARCH, INC. 42307 OSGOOD ROAD, SUITE I FREMONT CA 94539 true See remarks Class A Common Stock 2022-08-16 4 M 0 5000 4.62 A 135002 D Class A Common Stock 2022-08-16 4 S 0 5000 19.42 D 130002 D Class A Common Stock 2022-08-17 4 M 0 5000 4.62 A 135002 D Class A Common Stock 2022-08-17 4 S 0 9182 17.5 D 125820 D Class A Common Stock 2022-08-17 4 S 0 5818 18.29 D 120002 D Stock Option 4.62 2022-08-16 4 M 0 5000 0 D 2028-07-31 Class A Common Stock 5000 40000 D Stock Option 4.62 2022-08-17 4 M 0 5000 0 D 2028-07-31 Class A Common Stock 5000 35000 D On August 16, 2022, the reporting person exercised a previously issued stock option to purchase 5,000 shares of Class A Common Stock of the Issuer. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. On August 17, 2022, the reporting person exercised a previously issued stock option to purchase 5,000 shares of Class A Common Stock of the Issuer. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.27 to $19.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5) and (6) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.13 to $18.06, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.16 to $18.53, inclusive. The option is fully vested and exercisable. Senior Vice President, Manufacturing of ACM Research (Shanghai), Inc., a subsidiary of the Issuer. Exhibit List: Exhibit 24 - Power of Attorney /s/ Mark McKechnie, Attorney-in-Fact for Sotheara Cheav 2022-08-18 EX-24 2 brhc10041045_ex24.htm EXHIBIT 24
Exhibit 24

POWER OF ATTORNEY
(For Executing Forms ID, 3, 4 and 5 for Filing with the Securities and Exchange Commission)
 
Know all by these present, that the undersigned hereby constitutes and appoints each of Mark McKechnie of ACM Research, Inc. and Bella Zaslavsky, Hillary Pellerin O’Rourke, Andrew H. Galtieri of K&L Gates LLP, severally with full power of substitution, as the undersigned’s true and lawful attorneys‑in‑fact to:
 
 (1)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the Securities and Exchange Commission (the “SEC”) a Form ID, Uniform Application for Access Codes to File on EDGAR, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or any rule or regulation thereunder;
 
(2)
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the SEC from time to time Forms 3, 4 and 5 (including amendments thereto and joint filing agreements in connection therewith) in accordance with Section 16(a) of the Exchange Act and the rules thereunder in the undersigned’s capacity as an officer, director or beneficial owner of more than ten percent of a registered class of securities of various entities (collectively, the “Company”);
 
(3)
do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to prepare and execute any such Form 3, 4 or 5 (including amendments thereto and joint filing agreements in connection therewith) and file such forms with the SEC and any stock exchange, self-regulatory association or any similar authority; and
 
(4)
take any other action of any type whatsoever in connection with the foregoing that, in the opinion of such attorney‑in‑fact, may be of benefit to, in the best interest of, or legally required of the undersigned, it being understood that the documents executed by either attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney‑in‑fact may approve in the attorney-in-fact’s discretion.
 
The undersigned hereby grants to each such attorney‑in‑fact, severally, full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that either such attorney‑in‑fact, or such attorney‑in‑fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that, in serving in such capacity at the request of the undersigned, neither of the foregoing attorneys-in-fact, or their substitutes, is assuming (nor is the Company assuming) any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.
 
This Power of Attorney shall remain in full force and effect until the earliest to occur of (a) the time as of which the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, (b) revocation of this Power of Attorney by the undersigned in a signed writing delivered to the Company and the foregoing attorneys‑in‑fact and (c) with respect to either attorney-in-fact, the time as of which such attorney-in-fact is no longer affiliated with K&L Gates LLP.
 
In Witness Whereof, the undersigned has caused this Power of Attorney to be executed as of the date written below.
 
Date: August 16, 2022
     
By:
/s/ Sotheara Cheav
  
 
Sotheara Cheav